SKI Market

Indian Indices

Sensex

79,686.66 -329.24
( -0.41%)

Global Indices

Nasdaq

47,963.68 -796.74
(-1.63%)

Dow Jones

6,850.98 -39.52
(-0.57%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,430.91 -136.74
(-1.29%)

Forex

USD-INR

92.13 0.17
(0.19%)

EUR-INR

107.06 0.12
(0.11%)

GBP-INR

123.03 0.33
(0.27%)

JPY-INR

0.59 0.00
(0.39%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.12

2785.85

EPS(TTM)

Face Value()

Div & Yield %

5.04

0.04

Back

Visagar Financial Services standalone net profit rises 58.24% in the December 2025 quarter

Feb 13,2026

Net profit of Visagar Financial Services rose 58.24% to Rs 1.44 crore in the quarter ended December 2025 as against Rs 0.91 crore during the previous quarter ended December 2024. Sales declined 73.97% to Rs 2.98 crore in the quarter ended December 2025 as against Rs 11.45 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.98	11.45	-74
OPM %	50.67	8.91	-
PBDT	1.46	0.96	52
PBT	1.44	0.91	58
NP	1.44	0.91	58

79,686.66 -329.24 ( -0.41%)

47,963.68 -796.74 (-1.63%)

6,850.98 -39.52 (-0.57%)

55,141.42 895.88 (1.65%)

10,430.91 -136.74 (-1.29%)

92.13 0.17 (0.19%)

107.06 0.12 (0.11%)

123.03 0.33 (0.27%)

0.59 0.00 (0.39%)